They are not intended to represent clinical evidence in humans, and Epithalon has not been approved by the FDA, EMA, or any other regulatory authority for any indication
doi:10.4088/jcp.v62n07a05CrossRefGoogle ScholarPubMed Hollander, E, Chaplin, W, Soorya, L, et al
That pairing isn't arbitrary these two compounds operate on different parts of the same axis and produce a growth hormone pulse that neither can generate alone with the same magnitude or quality
When lifestyle changes have not achieved the desired results, liposuction may be recommended
The FDA could issue an interim enforcement policy stating that it does not intend to act against qualifying pharmacies that compound these substances under set conditions while the formal process plays out